Skip to main content
ToolsForensic Analysisequity pharmaceuticals

equity pharmaceuticals

Supplier Forensic Analysis · Scanned: 2026/06/24

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
2
Total Value
R 63M

Recent Awards

2 awards · Total: R 62 973 626,24

Showing 5 of 2
HP04-2024ONC: Supply and Delivery of Oncology and Immunological Agents to the Department of Health for the period ending 30 June 2026.
Health
Ref: HP04-2024ONC/02
R 4 109 706,92
22 Dec 2025
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AI
R 58 863 919,32
15 Jun 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Risk Assessment

Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →